Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer.

RPEP-111582025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer.
Published In:
Journal of controlled release : official journal of the Controlled Release Society, 387, 114269 (2025)
Database ID:
RPEP-11158

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11158·https://rethinkpeptides.com/research/RPEP-11158

APA

Gorzeń, Oliwia; Łęcka, Maria; Ćwilichowska-Puślecka, Natalia; Majchrzak, Martyna; Horbach, Natalia; Wiśniewski, Jerzy; Jakimowicz, Piotr; Szpot, Paweł; Zawadzki, Marcin; Dołęga-Kozierowski, Bartosz; Kasprzak, Piotr; Turk, Boris; Drąg, Marcin; Groborz, Katarzyna M; Matkowski, Rafał; Poręba, Marcin. (2025). Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer.. Journal of controlled release : official journal of the Controlled Release Society, 387, 114269. https://doi.org/10.1016/j.jconrel.2025.114269

MLA

Gorzeń, Oliwia, et al. "Engineering unnatural amino acids in peptide linkers enables cathepsin-selective antibody-drug conjugates for HER2-positive breast cancer.." Journal of controlled release : official journal of the Controlled Release Society, 2025. https://doi.org/10.1016/j.jconrel.2025.114269

RethinkPeptides

RethinkPeptides Research Database. "Engineering unnatural amino acids in peptide linkers enables..." RPEP-11158. Retrieved from https://rethinkpeptides.com/research/gorzen-2025-engineering-unnatural-amino-acids

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.